Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer
Status:
Completed
Trial end date:
2001-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug or giving drugs in different ways may
kill more tumor cells.
PURPOSE: Randomized phase II trial to compare the effectiveness of gemcitabine with or
without CI-994 in treating patients who have advanced pancreatic cancer.